Get the Stockscreener App
3.30
1.20%
-0.04
Autolus Therapeutics Plc Adr stock is traded at $3.30, with a volume of 551.41K.
It is down -1.20% in the last 24 hours and down -17.09% over the past month.
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
See More
Previous Close:
$3.34
Open:
$3.35
24h Volume:
551.41K
Relative Volume:
0.59
Market Cap:
$888.76M
Revenue:
-
Net Income/Loss:
$-208.38M
P/E Ratio:
-2.7731
EPS:
-1.19
Net Cash Flow:
$-156.57M
1W Performance:
-23.96%
1M Performance:
-17.09%
6M Performance:
-21.24%
1Y Performance:
-19.32%
1-Day Range:
$3.235
$3.40
1-Week Range:
$3.235
$4.36
52-Week Range:
$3.06
$7.45
Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile
Name
Autolus Therapeutics Plc Adr
Sector
Industry
Phone
44 20 3829 6230
Address
THE MEDIAWORKS, LONDON
Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Mar-27-23 | Resumed | Wells Fargo | Overweight |
| Mar-17-23 | Initiated | Bryan Garnier | Buy |
| Jun-14-21 | Upgrade | Jefferies | Hold → Buy |
| Jan-29-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-28-20 | Resumed | H.C. Wainwright | Buy |
| Jul-31-20 | Initiated | JP Morgan | Overweight |
| Jul-22-20 | Initiated | SunTrust | Buy |
| Apr-22-20 | Initiated | Mizuho | Buy |
| Sep-23-19 | Initiated | Needham | Buy |
| May-17-19 | Reiterated | H.C. Wainwright | Buy |
| Oct-24-18 | Initiated | H.C. Wainwright | Buy |
View All
Autolus Therapeutics Plc Adr Stock (AUTL) Latest News
PDD Holdings Inc ADR (NASDAQ: PDD) Has Been Trading Down. What Are The Prospects For The Future? - Stocks Register
What Do Wall Street Analysts Think About Moderna Inc (NASDAQ: MRNA) Stock? - Stocks Register
Before You Invest, Make Sure You Check This Autolus Therapeutics plc ADR (NASDAQ: AUTL) Analysis - Stocks Register
Autolus Therapeutics plc ADR (AUTL)’s stock rises to 4.14 per share - US Post News
Autolus Therapeutics plc ADR: -44.83% Growth from 52-Week Low, Yet Analysts Divided - The InvestChronicle
A better buy-in window may exist right now for Autolus Therapeutics plc ADR (AUTL) - SETE News
Upward Trajectory: Autolus Therapeutics plc ADR (AUTL) Posts a Slidee, Closing at 3.98 - The Dwinnex
Autolus Therapeutics plc ADR (AUTL) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
Are Smart Investors Making the Right Decision? Autolus Therapeutics plc ADR (AUTL) - SETE News
Autolus Therapeutics plc ADR (AUTL) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Autolus Therapeutics plc ADR (AUTL)’s stock chart: A technical perspective - US Post News
Stock Performance Spotlight: Autolus Therapeutics plc ADR (AUTL) Ends the Day at 3.63, Up by 4.31 - The Dwinnex
A look into Autolus Therapeutics plc ADR (AUTL)’s deeper side - SETE News
Are Autolus Therapeutics plc ADR (AUTL) shares a good deal now? - US Post News
Autolus Therapeutics plc ADR (AUTL)’s Market Momentum: Closing Strong at 3.73, Down -3.12 - The Dwinnex
Autolus Therapeutics (NASDAQ:AUTL) Shares Down 4.8% - MarketBeat
Autolus Therapeutics names new Chief Development Officer - Investing.com India
Autolus Therapeutics names new Chief Development Officer By Investing.com - Investing.com South Africa
Autolus Therapeutics plc (NASDAQ:AUTL) Short Interest Down 8.0% in August - Defense World
Autolus Therapeutics plc ADR (AUTL) looking to reclaim success with recent performance - SETE News
Autolus Therapeutics plc ADR (AUTL) Stock: Navigating a Year of Volatility - The InvestChronicle
Autolus Therapeutics plc (NASDAQ:AUTL) Shares Acquired by Daiwa Securities Group Inc. - Defense World
Autolus Therapeutics plc ADR (AUTL)’s stock price in review: A technical analysis - US Post News
Autolus Therapeutics (NASDAQ:AUTL) Shares Gap Up to $4.08 - MarketBeat
Financial Metrics Check: Autolus Therapeutics plc ADR (AUTL)’s Ratios for Trailing Twelve Months - The Dwinnex
Autolus secures £18.5M for facility upgrades - Investing.com
Autolus Therapeutics plc ADR (AUTL) is looking forward to a strong quarter - SETE News
Trading Day Review: Autolus Therapeutics plc ADR (AUTL) Gains Momentum, Closing at 4.12 - The Dwinnex
Autolus Therapeutics plc ADR (AUTL) presents a great opportunity, but the stock is slightly overvalued - US Post News
Autolus Therapeutics (NASDAQ:AUTL) Stock Price Up 6% - MarketBeat
Autolus Therapeutics (NASDAQ:AUTL) Stock Price Down 3.4% - MarketBeat
It is Poised to be a Bull Market for Autolus Therapeutics plc ADR (AUTL) - SETE News
Contrasting Autolus Therapeutics (NASDAQ:AUTL) & ZIVO Bioscience (NASDAQ:ZIVO) - Defense World
Lucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today - GlobeNewswire Inc.
Autolus reports promising results for obe-cel in leukemia study - Investing.com India
Views of Wall Street’s Leading Experts on Autolus Therapeutics plc ADR - SETE News
Is Autolus Therapeutics plc ADR (AUTL) a good investment opportunity? - US Post News
SG Americas Securities LLC Purchases 169,387 Shares of Autolus Therapeutics plc (NASDAQ:AUTL) - Defense World
Take off with Autolus Therapeutics plc ADR (AUTL): Get ready for trading - SETE News
Examining Autolus Therapeutics plc ADR (AUTL) stock is warranted - US Post News
Autolus Therapeutics plc ADR (AUTL)’s Market Momentum: Closing Strong at 3.75, Up 1.90 - The Dwinnex
Financial Survey: Autolus Therapeutics (NASDAQ:AUTL) and Cognition Therapeutics (NASDAQ:CGTX) - Defense World
Autolus Therapeutics (NASDAQ:AUTL) Shares Gap Up to $3.64 - Defense World
Cetera Advisors LLC Invests $839,000 in Autolus Therapeutics plc (NASDAQ:AUTL) - Defense World
How Analyst Ratings Affect Autolus Therapeutics plc ADR Inc. (AUTL) Price Performance - The InvestChronicle
Understanding the Risks and Rewards of Investing in SES AI Corporation Inc. (SES) Based on Price Performance - The InvestChronicle
Aptiv PLC: Rising -36.09% from 52-Week Low, Can the Stock Stay Afloat? - The InvestChronicle
i-80 Gold Corp (IAUX) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Investor’s Delight: Autolus Therapeutics plc ADR (AUTL) Closes Weak at 3.90, Down -8.24 - The Dwinnex
Have you been able to find a good deal on Autolus Therapeutics plc ADR’s shares? - US Post News
Stock Performance Spotlight: Autolus Therapeutics plc ADR (AUTL) Ends the Day at 4.47, Down by -3.46 - The Dwinnex
Autolus Therapeutics Plc Adr Stock (AUTL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):